Reference
Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System Clinical Drug Investigation : 13 Jan 2023. Available from: URL: https://link.springer.com/article/10.1007/s40261-022-01242-7#Sec11
Rights and permissions
About this article
Cite this article
DPP-4 inhibitors have differing AE trends. Reactions Weekly 1940, 9 (2023). https://doi.org/10.1007/s40278-023-31867-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-31867-1